Joint Position Statement on the Management of Mesh-Related Complications for the FPMRS Specialist
- PMID: 32118617
- DOI: 10.1097/SPV.0000000000000853
Joint Position Statement on the Management of Mesh-Related Complications for the FPMRS Specialist
Abstract
The scientific approach to categorizing mesh complications and optimal methods to address them have been complicated by the rapid proliferation and evolution of materials and techniques that have been used over the past 20 years in surgical treatment of pelvic floor disorders. In addition, terminology used to diagnose and categorize mesh complications and the descriptions of surgical procedures to manage them have been adopted inconsistently, further hampering the development of a collective experience with a standardized lexicon. Finally, much of the high-quality data on management of mesh complications is based on materials that are rarely used or not commercially available today.Women experiencing mesh complications need to be heard and should have access to resources and providers who are most able to help. Many women require multiple procedures to address their mesh complications, and for some of these patients, relief is incomplete. We should strive to optimize the treatment at the initial diagnosis of a mesh-related complication.This Position Statement has 4 goals:1. Using the best and most relevant evidence available, provide guidance for the FPMRS subspecialist caring for patients who may be experiencing mesh complications2: Provide an algorithm outlining treatment choices for patients with mesh-related complications that can be used as a platform for shared decision making in the treatment of these complications3: Identify and prioritize gaps in evidence concerning specific mesh complications and their treatments4: Identify provider and health facility characteristics that may optimize the outcomes of treatments for these complications.
Similar articles
-
Joint position statement on the management of mesh-related complications for the FPMRS specialist.Int Urogynecol J. 2020 Apr;31(4):679-694. doi: 10.1007/s00192-020-04248-x. Int Urogynecol J. 2020. PMID: 32112158
-
FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases series 4: is taking out all of a mesh sling too extreme?Int Urogynecol J. 2020 Feb;31(2):221-225. doi: 10.1007/s00192-019-04172-9. Epub 2019 Dec 2. Int Urogynecol J. 2020. PMID: 31792592 No abstract available.
-
Management of Mesh and Graft Complications in Gynecologic Surgery.Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):171-176. doi: 10.1097/SPV.0000000000000425. Female Pelvic Med Reconstr Surg. 2017. PMID: 28398930
-
Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence.Eur Urol. 2017 Sep;72(3):424-431. doi: 10.1016/j.eururo.2017.03.048. Epub 2017 Apr 14. Eur Urol. 2017. PMID: 28413126 Review.
-
Complications related to use of mesh implants in surgical treatment of stress urinary incontinence and pelvic organ prolapse: infection or inflammation?World J Urol. 2020 Jan;38(1):73-80. doi: 10.1007/s00345-019-02679-w. Epub 2019 Feb 13. World J Urol. 2020. PMID: 30759272 Free PMC article. Review.
Cited by
-
Mesh complications: best practice in diagnosis and treatment.Ther Adv Urol. 2020 Jul 23;12:1756287220942993. doi: 10.1177/1756287220942993. eCollection 2020 Jan-Dec. Ther Adv Urol. 2020. PMID: 32754226 Free PMC article. Review.
-
Quality of life outcomes after transobturator tape full removal surgeries: A monocentric experience.BJUI Compass. 2024 Mar 20;5(5):454-464. doi: 10.1002/bco2.317. eCollection 2024 May. BJUI Compass. 2024. PMID: 38751946 Free PMC article.
-
Robotic sacrocolpopexy.Obstet Gynecol Sci. 2024 Mar;67(2):212-217. doi: 10.5468/ogs.23226. Epub 2024 Jan 18. Obstet Gynecol Sci. 2024. PMID: 38246693 Free PMC article.
-
Dysregulated wound healing in the pathogenesis of urogynecologic mesh complications.Sci Rep. 2023 Dec 5;13(1):21437. doi: 10.1038/s41598-023-48388-8. Sci Rep. 2023. PMID: 38052928 Free PMC article.
-
Perioperative Opioid Use in Urogynecologic Mesh Removal.Urogynecology (Phila). 2025 Jan 1;31(1):18-25. doi: 10.1097/SPV.0000000000001527. Urogynecology (Phila). 2025. PMID: 39692525
References
-
- Management of mesh and graft complications in gynecologic surgery. Committee Opinion No. 694. American College of Obstetricians and Gynecologists, American Urogynecologic Society. Female Pelvic Med Reconstr Surg 2017;23(3):171–176.
-
- Gyang AN, Feranec JB, Patel RC, et al. Managing chronic pelvic pain following reconstructive pelvic surgery with transvaginal mesh. Int Urogynecol J 2014;25:313–318.
-
- Crosby EC, Abernethy M, Berger MB, et al. Symptom resolution after operative management of complications from transvaginal mesh. Obstet Gynecol 2014;123(1):134–139.
-
- Haylen BT, Freeman RM, Swift SE, et al., International Urogynecological Association; International Continence Society; Joint IUGA/ICS Working Group on Complications Terminology. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. NeurourolUrodyn 2011;30(1):2–12.
-
- Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207–208.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous